Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis, Primary Progressive”

128 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 128 results

Testing effectiveness (Phase 2)Study completedNCT01450488
What this trial is testing

Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AB Science 35
Not applicableUnknownNCT06320444
What this trial is testing

Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral SclerosisMotor Neuron Disease Progressive Spinal Muscle AtrophyPrimary Lateral Sclerosis+2 more
University of Dublin, Trinity College 240
Not applicableStudy completedNCT04545372
What this trial is testing

Aerobic Exercises for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Primary Progressive
South Valley University 30
Testing effectiveness (Phase 2)Ended earlyNCT03283826
What this trial is testing

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Atara Biotherapeutics 134
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Post-approval studies (Phase 4)Looking for participantsNCT07609719
What this trial is testing

Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

Who this might be right for
Multiple Sclerosis
Genentech, Inc. 100
Not applicableStudy completedNCT07680738
What this trial is testing

Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, MSMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting+5 more
Universidad de Almeria 38
Not applicableActive Not RecruitingNCT06209515
What this trial is testing

Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study

Who this might be right for
Neurodegenerative DiseasesAlzheimer DiseaseFrontotemporal Dementia+8 more
Kuopio University Hospital 61,292
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Early research (Phase 1)Study completedNCT01381354
What this trial is testing

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Who this might be right for
Multiple Sclerosis
University of Iowa 38
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Large-scale testing (Phase 3)Study completedNCT01433497
What this trial is testing

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapse Free
AB Science 656
Not applicableStudy completedNCT05466682
What this trial is testing

RELAXaHEAD for Headache Patients (Phase II)

Who this might be right for
MigraineHeadacheMultiple Sclerosis+1 more
NYU Langone Health 48
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07477639
What this trial is testing

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis (SPMS)Multiple Sclerosis+2 more
Tr1X, Inc. 39
Not applicableStudy completedNCT06737419
What this trial is testing

Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 175
Not applicableEnded earlyNCT02016222
What this trial is testing

Tear Analysis in the Diagnosis of Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple Sclerosis
Lille Catholic University 80
Not applicableLooking for participantsNCT06596746
What this trial is testing

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseSynucleinopathies+15 more
Casa di Cura San Raffaele Cassino 600
Large-scale testing (Phase 3)Study completedNCT03606460
What this trial is testing

Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Multiple Sclerosis
Genentech, Inc. 141
Large-scale testing (Phase 3)Study completedNCT01917019
What this trial is testing

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more
Biogen 101
Next Page